Elsevier Inc.

SHERPA: Unknown

People

  1. Zhang
    Zhang
  2. Giralt
    Giralt
  3. Perales
    Perales
  4. Devlin
    Devlin
  5. Iasonos
    Iasonos
  6. Seshan
    Seshan
  7. Zhou
    Zhou
  8. Chi
    Chi
  9. Shah
    Shah
  10. Abu-Rustum
    Abu-Rustum

Groups

  1. Biostatistics Service (930)
  2. Epidemiology and Biostatistics (930)
  3. Department of Medicine (581)
  4. Survivorship Research (464)
  5. Surgery (371)
  6. Solid Tumor Oncology Division (322)
  7. Hematologic Malignancies, Division of (291)
  8. Radiation Oncology, Department of (273)
  9. Center for Hematologic Malignancies (266)
  10. GSK Faculty (239)
Search Within
  1. "Biostatistics Service"
Formats
  1. Journal Article (488)
  2. Meeting Abstract (429)
  3. Research Letter (5)
  4. Correspondence (3)
  5. Conference Paper (2)
  6. Book Section (1)
  7. Editorial (1)
  8. Review (1)
Groups
  1. Biostatistics Service (930)
  2. Epidemiology and Biostatistics (930)
  3. Department of Medicine (581)
  4. Survivorship Research (464)
  5. Surgery (371)
  6. Solid Tumor Oncology Division (322)

More Groups

People
  1. Zhigang Zhang (213)
  2. Sean Devlin (175)
  3. Sergio Giralt (173)
  4. Miguel-Angel Perales (124)
  5. Alexia Iasonos (113)
  6. Venkatraman Seshan (94)

More People

Years
  1. 2025 (12)
  2. 2024 (67)
  3. 2023 (67)
  4. 2022 (52)
  5. 2021 (50)
  6. 2020 (59)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (233)
  2. Biology of Blood and Marrow Transplantation (174)
  3. Gynecologic Oncology (157)
  4. Journal of Thoracic Oncology (90)
  5. Clinical Lymphoma, Myeloma and Leukemia (35)
  6. Transplantation and Cellular Therapy (28)

More Publications

Results (930)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of cfDNA testing for acquired resistance: The Memorial Sloan Kettering experience with plasma EGFR T790M clinical testing
    Meeting Abstract

    Offin, M.; Myers, M.; Josyula, S.; Shen, R.; Borsu, L.; Tsui, D.; Riely, G.; Rudin, C.; Yu, H.; Li, B.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Impact of tumor spread through air spaces (STAS) in lung neuroendocrine tumors (NETs)
    Meeting Abstract

    Aly, R.; Eguchi, T.; Kadota, K.; Rekhtman, N.; Tan, K. S.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Concurrent mutations in STK11 and KEAP1 is associated with resistance to PD-(L)1 blockade in patients with NSCLC despite high TMB
    Meeting Abstract

    Arbour, K.; Shen, R.; Plodkowski, A.; Rizvi, H.; Ni, A.; Long, N.; Halpenny, D.; Sanchez-Vega, F.; Rudin, C.; Riely, G.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • An ex-vivo patient-derived, immunocompetent (PDI) culture system to evaluate immunotherapeutic agents' anti-tumor efficacy
    Meeting Abstract

    Tano, Z.; Kiesgen, S.; Chintala, N.; Dozier, J.; Messinger, J.; Tan, K. S.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • gC1qR expression is independently prognostic for survival benefit following chemotherapy in mesothelioma
    Meeting Abstract

    Li, X.; Eguchi, T.; Aly, R.; Chintala, N.; Tan, K. S.; Messinger, J.; Zauderer, M.; Ghebrehiwet, B.; Adusumilli, P.; Peerschke, E.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of EGFR mutant lung cancers with concurrent TP53 and RB1 mutations
    Meeting Abstract

    Offin, M.; Tenet, M.; Shen, R.; Rekhtman, N.; Rizvi, H.; Hellmann, M.; Arcila, M.; Ladanyi, M.; Rudin, C.; Kris, M.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Immune microenvironment and its association with adjuvant chemotherapy benefit in locoregionally advanced lung adenocarcinoma
    Meeting Abstract

    Vaghjiani, R.; Eguchi, T.; Chintala, N.; Li, X.; Aly, R.; Emoto, K.; Tan, K. S.; Jones, D.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Histologic subtyping in pathologic stage I lung adenocarcinoma provides risk-based stratification for surveillance
    Meeting Abstract

    Takahashi, Y.; Eguchi, T.; Kameda, K.; Lu, S.; Vaghjiani, R.; Tan, K. S.; Jones, D.; Travis, W.; Adusumilli, P.
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Comparison of radiographic approaches to assess treatment response in pituitary adenomas: Are RECIST/RANO good enough?
    Meeting Abstract

    Imber, B. S.; Yang, T. J.; Zhigang, Z.; Beal, K.; Cohen, M.; Tabar, V. S.; Geer, E. B.; Lin, A.; Young, R. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • A phase 1 clinical trial of ipilimumab, nivolumab and radiation therapy for patients with metastatic melanoma
    Meeting Abstract

    Barker, C. A.; Postow, M. A.; Goldman, D. A.; Panageas, K. S.; Halpenny, D.; McCabe, D.; Macri, M.; Schwarzenberger, P.; Ricciardi, T.; Ryan, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save